|
시장보고서
상품코드
1375076
아시아태평양의 의료용 경피 흡수성 패치 시장 예측(-2028년) - 지역별 분석 : 유형, 용도 및 유통 채널별Asia Pacific Transdermal Medical Patch Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and Distribution Channel |
||||||
아시아태평양의 의료용 경피 흡수 패치 시장은 2023년 21억 2,631만 달러에서 2028년 27억 4,432만 달러로 성장할 것으로 예상되며, 2023년부터 2028년까지 5.2%의 CAGR을 나타낼 것으로 추정됩니다.
스마트 패치와 3차원(3D) 프린팅 패치의 발전으로 아시아태평양 의료용 경피흡수 패치 시장 활성화
경피적 약물 투여 경로는 새롭고 신뢰할 수 있는 지속적 약물 전달 수단 중 하나입니다. 이 분야에서 중요한 연구가 이루어지고 있으며, 이 형태의 약물 전달에 대한 연구자들의 관심이 높아짐에 따라 시장에 출시되는 경피 패치의 수가 급증할 것으로 예상됩니다. 경피 패치는 수십년전부터 주목을 받아왔으며, 니코틴, 펜타닐, 니트로글리세린, 클로니딘과 같은 약물을 전달하고 다양한 질병과 증상을 치료하는 데 사용되어 왔습니다.
2022년에 발표된 'A smart hydrogel patch with high transparency, adhesiveness, and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers"라는 제목의 연구에 따르면, 과학자들은 당뇨병성 족부 궤양을 모니터링하고 치료하기 위한 지능형 패치를 개발했습니다. 이 시스템은 초투명 고분자 네트워크가 있는 전도성 하이드로겔 패치로 만들어졌습니다.
연구진은 3D 프린팅 기술을 활용하여 환자의 필요에 따라 맞춤형 경피 패치(예: 상처 치유를 위한 3D 프린팅 패치)를 제작하고 있습니다.2022년에 발표된 Jang et al. for Tissue Engineering Applications-A Review on Material Modifications(조직공학 응용을 위한 젤라틴 메타크릴레이트 하이드로겔-재료 개질에 대한 총론)'라는 제목의 연구에서 젤라틴 메타크릴레이트 하이드로겔(GelMA) GelMA)가 물리적 특성을 조절할 수 있는 실행 가능한 대안으로 시험되었습니다. 혈관내피성장인자(VEGF)를 모방한 펩타이드가 포함된 GelMA 하이드로겔은 하이드로겔 잉크의 전단감점 특성으로 인해 3D 바이오 프린터를 통해 인쇄에 성공했습니다. 하이드로겔 패치의 3D 구조는 높은 다공성과 흡수성을 가지고 있었습니다. 하이드로겔 패치에서 천천히 방출되는 VEGF 펩타이드는 세포 생존율, 증식, 관형 구조 형성을 촉진할 수 있어 3D Gel-MA-VEGF 하이드로겔 패치가 상처 치료용으로 사용될 수 있음을 보여주었습니다.
이 연구에서는 폴리에틸렌 글리콜 디 아크릴 레이트(PEGDA)와 비닐 피 롤리 돈(VP)의 두 가지 액체 단량체를 서로 다른 비율로 사용하여 최종 폴리머의 기계적 강도, 중합 속도 및 부풀어 오르는 속도를 향상 시켰습니다. 수지에 최적의 약물 부하를 통해 AHP-3는 제조 공정 전반에 걸쳐 안정적이고 최종 폴리머의 물성에 영향을 미치지 않는 것으로 나타났으며, 3D 스캔한 얼굴 모델을 사용하여 컴퓨터 지원 설계 소프트웨어로 개인 맞춤형 패치를 설계하고 디지털 광학 가공 3D 프린터 를 통해 최적화된 수지로 제작되었습니다. 제작된 경피 패치의 시험관 내 특성 평가 결과, 인체 시체 피부에 침투할 수 있는 능력을 보여주었고, 압축 후에도 손상되지 않았습니다.
아태지역 의료용 경피흡수 패치 시장 개요
아시아태평양의 의료용 경피흡수 패치 시장은 호주, 중국, 인도, 일본, 한국 및 기타 아시아태평양으로 구분됩니다. 이 지역의 성장 배경에는 암 및 유전자 돌연변이에 대한 연구 확대, 질병 모델링 증가, 의료용 경피흡수 패치를 제공하는 시장 개척이 있습니다. 의료시설의 발전, 줄기세포 기술과 관련된 중요한 사실을 공유하는 고령화 인구 증가, 해외 사업체와의 파트너십 증가와 같은 주요 발전 요인은 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 보입니다.
아시아태평양 의료용 경피흡수 패치 시장 수익 및 2028년까지의 예측(금액)
아시아태평양의 의료용 경피 흡수성 패치 시장 세분화
아시아태평양의 의료용 경피 흡수 패치 시장은 유형, 용도, 유통 채널 및 국가별로 분류됩니다.
유형별로 아시아태평양의 의료용 경피 흡수 패치 시장은 단층 약물 접착제, 다층 약물 접착제, 저장소, 증기 패치 및 매트릭스로 분류되며, 2023년 아시아태평양의 의료용 경피 흡수 패치 시장에서 매트릭스 부문이 가장 큰 시장 점유율을 기록했습니다.
용도별로는 아시아태평양 의료용 경피흡수 패치 시장은 신경질환, 통증 관리, 니코틴 금연, 심혈관 질환, 호르몬 요법, 기타로 구분되며, 2023년에는 통증 관리 분야가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
아시아태평양의 의료용 경피 흡수 패치 시장은 유통 채널에 따라 병원 약국, 소매 약국, 온라인 약국으로 구분됩니다. 병원 약국 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 보면 아시아태평양의 의료용 경피 흡수 패치 시장은 호주, 중국, 인도, 일본, 한국 및 기타 아시아태평양으로 구분되며, 2022년 시장 점유율은 일본이 독주할 것으로 예상됩니다.
Boehringer Ingelheim International GmbH, Endo International Inc, Kugo Pharmaceuticals, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc. 등이 이 지역의 의료용 경피흡수 패치 시장에서 활동하는 주요 기업입니다.
목차
제1장 서론
제2장 의료용 경피 흡수 패치 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 아시아태평양의 의료용 경피 흡수 패치 시장 - 시장 구도
- 개요
- PEST 분석
- 아시아태평양의 PEST 분석
- 전문가의 견해
제5장 아시아태평양의 의료용 경피 흡수 패치 시장 : 주요 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 향후 동향
- 영향 분석
제6장 아시아태평양의 의료용 경피 흡수 패치 시장 분석
- 아시아태평양의 의료용 경피 흡수 패치 시장 매출과 예측 분석
제7장 아시아태평양의 의료용 경피 흡수 패치 시장 - 유형별 매출과 2028년까지 예측
- 의료용 경피 흡수 패치 시장 유형별 매출 점유율(2022년, 2028년)
- 단층형 약물 접착제
- 다층 약물 접착제
- 리저버
- 증기 패치
- 매트릭스
제8장 아시아태평양의 의료용 경피 흡수 패치 시장 : 용도별 매출과 2028년까지 예측
- 의료용 경피 흡수 패치 시장 용도별 판매량 점유율(2022년, 2028년)
- 신경질환
- 통증 관리
- 니코틴 중단
- 심혈관질환
- 호르몬 요법
- 기타
제9장 아시아태평양의 의료용 경피 흡수 패치 시장 - 2028년에 이르는 매출과 예측-판매채널별
- 의료용 경피 흡수 패치 시장 유통 채널별 매출 점유율(2022년 및 2028년)
- 병원 약국
- 소매 약국
- 온라인 약국
제10장 의료용 경피 흡수 패치 시장 : 2028년까지 매출과 예측 : 국가별 분석
- 아시아태평양
제11장 업계 상황
- 성장 전략
제12장 기업 개요
- Hisamitsu Pharmaceutical Co Inc
- Medline Industries LP
- Johnson & Johnson
- Novartis AG
- Teva Pharmaceutical Industries Ltd
- Viatris Inc
- Endo Pharmaceuticals Inc
- Boehringer Ingelheim International GmbH
제13장 부록
LSH 23.11.14The Asia Pacific transdermal medical patch market is expected to grow from US$ 2,126.31 million in 2023 to US$ 2,744.32 million by 2028. It is estimated to register a CAGR of 5.2% from 2023 to 2028.
Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches Fuel Asia Pacific Transdermal Medical Patch Market
The transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being carried out in this field and increasing interest of researchers in this form of drug delivery, the number of transdermal patches reaching the marketplace is expected to rise sharply. Transdermal patches have attracted attention for decades and were used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various diseases or conditions.
According to a study titled "A smart hydrogel patch with high transparency, adhesiveness, and hemostasis for all-round treatment and glucose monitoring of diabetic foot ulcers," published in 2022, scientists have developed an intelligent patch to monitor and treat diabetic foot ulcers. This system is fabricated from conductive hydrogel patches with an ultra-high transparency polymer network.
Researchers are using 3D printing technology to create customized transdermal patches (e.g., a 3D-printed patch for wound healing) tailored as per patient's needs. In a study by Jang et al. titled "Gelatin Methacrylate Hydrogel for Tissue Engineering Applications-A Review on Material Modifications," published in 2022, gelatin methacrylate (GelMA) was tested as a viable option with tunable physical properties. GelMA hydrogel incorporating a vascular endothelial growth factor (VEGF)-mimicking peptide was successfully printed using a 3D bio-printer due to the hydrogel inks' shear-thinning properties. The 3D structure of the hydrogel patch had high porosity and water absorption properties. Slowly released from hydrogel patches, VEGF peptide can promote cell viability, proliferation, and tubular structure formation, indicating that the 3D Gel-MA-VEGF hydrogel patch can be used for wound dressing.
In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-in different proportions were used to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software and fabricated in optimized resin using a digital light processing 3D printer. In vitro characterization of the prepared transdermal patches showed their ability to penetrate human cadaver skin, and they remained intact after compression.
Asia Pacific Transdermal Medical Patch Market Overview
The transdermal medical patch market in Asia Pacific is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch. Factors such as developing healthcare facilities, growing aging population to share key facts associated with stem cell technologies, and increasing partnerships with foreign entities are likely to further propel the market growth during the forecast period.
Asia Pacific Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Transdermal Medical Patch Market Segmentation
The Asia Pacific transdermal medical patch market is segmented into type, application, distribution channel, and country.
Based on type, the Asia Pacific transdermal medical patch market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch, and matrix. The matrix segment registered the largest market share in Asia Pacific transdermal medical patch market in 2023.
Based on application, the Asia Pacific transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment held the largest market share in 2023.
Based on distribution channel, the Asia Pacific transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.
Based on country, the Asia Pacific transdermal medical patch market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Japan dominated the market share in 2022.
Boehringer Ingelheim International GmbH, Endo International Inc, Hisamitsu Pharmaceutical Co Inc, Johnsons and Johnsons, Medline Industries LP, Novartis AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific transdermal medical patch market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving transdermal medical patch market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Asia Pacific Transdermal Medical Patch Market - by Type
- 1.3.2 Asia Pacific Transdermal Medical Patch Market - by Application
- 1.3.3 Asia Pacific Transdermal Medical Patch Market - by Distribution Channel
- 1.3.4 Asia Pacific Transdermal Medical Patch Market - by Country
2. Transdermal Medical Patch Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Transdermal Medical Patch Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
- 4.3 Expert's Opinion
5. Asia Pacific Transdermal Medical Patch Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Consumption of Tobacco
- 5.2 Market Restraints
- 5.2.1 Recalls of Transdermal Medical Patches due to Drug Failure
- 5.3 Market Opportunities
- 5.3.1 Increasing Strategic Initiatives
- 5.4 Future Trends
- 5.4.1 Advancements in Smart Patches and Three-Dimensional (3D)-Printed Patches
- 5.5 Impact analysis
6. Transdermal Medical Patch Market - Asia Pacific Analysis
- 6.1 Asia Pacific Transdermal Medical Patch Market Revenue Forecast and Analysis
7. Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Type
- 7.1 Overview
- 7.2 Transdermal Medical Patch Market Revenue Share, by Type (2022 and 2028)
- 7.3 Single-Layer Drug In-Adhesive
- 7.3.1 Overview
- 7.3.2 Single-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Multi-Layer Drug In-Adhesive
- 7.4.1 Overview
- 7.4.2 Multi-Layer Drug In-Adhesive: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Reservoir
- 7.5.1 Overview
- 7.5.2 Reservoir: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 Vapor Patch
- 7.6.1 Overview
- 7.6.2 Vapor Patch: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Matrix
- 7.7.1 Overview
- 7.7.2 Matrix: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Application
- 8.1 Overview
- 8.2 Transdermal Medical Patch Market Revenue Share, by Application (2022 and 2028)
- 8.3 Neurologic Conditions
- 8.3.1 Overview
- 8.3.2 Neurologic Conditions: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Pain Management
- 8.4.1 Overview
- 8.4.2 Pain Management: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Nicotine Cessation
- 8.5.1 Overview
- 8.5.2 Nicotine Cessation: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Cardiovascular Disorders
- 8.6.1 Overview
- 8.6.2 Cardiovascular Disorders: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Hormonal Therapy
- 8.7.1 Overview
- 8.7.2 Hormonal Therapy: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Transdermal Medical Patch Market - Revenue and Forecast to 2028 - By Distribution Channels
- 9.1 Overview
- 9.2 Transdermal Medical Patch Market Revenue Share, by Distribution Channels (2022and 2028)
- 9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Retail Pharmacies
- 9.4.1 Overview
- 9.4.2 Retail Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Online Pharmacies
- 9.5.1 Overview
- 9.5.2 Online Pharmacies: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
10. Transdermal Medical Patch Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 Asia-Pacific: Transdermal Medical Patch Market
- 10.1.1 Overview
- 10.1.2 Asia-Pacific: Transdermal Medical Patch Market, by Country, 2022 & 2028 (%)
- 10.1.2.1 China: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.1.1 Overview
- 10.1.2.1.2 China: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.1.3 China: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.1.4 China: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.1.5 China: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.2 Japan: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.2.1 Overview
- 10.1.2.2.2 Japan: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.2.3 Japan: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.2.4 Japan: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.2.5 Japan: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.3 India: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.3.1 Overview
- 10.1.2.3.2 India: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.3.3 India: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.3.4 India: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.3.5 India: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.4 South Korea: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.4.1 Overview
- 10.1.2.4.2 South Korea: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.4.3 South Korea: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.4.4 South Korea: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.4.5 South Korea: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.5 Australia: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.5.1 Overview
- 10.1.2.5.2 Australia: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.5.3 Australia: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.5.4 Australia: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.5.5 Australia: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.6 Rest of Asia-Pacific: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.6.1 Overview
- 10.1.2.6.2 Rest of Asia-Pacific: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.2.6.3 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Type, 2020-2028 (US$ Million)
- 10.1.2.6.4 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Applications, 2020-2028 (US$ Million)
- 10.1.2.6.5 Rest of Asia-Pacific: Transdermal Medical Patch Market, by Distribution Channels 2020-2028 (US$ Million)
- 10.1.2.1 China: Transdermal Medical Patch Market - Revenue and Forecast to 2028 (US$ Million)
11. Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies
- 11.2.1 Overview
12. Company Profiles
- 12.1 Hisamitsu Pharmaceutical Co Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Medline Industries LP
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Johnson & Johnson
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Novartis AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Viatris Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Endo Pharmaceuticals Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Boehringer Ingelheim International GmbH
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
